1. Efficacy and tolerability of the Subcutaneous Semaglutide for type 2 Diabetes patients: an updated systematic review and meta-analysis
   Shanshan Hu et al, 2023, Diabetology & Metabolic Syndrome CrossRef
2. Silencing of YTHDF1 Attenuates Cerebral Stroke by Inducing PTEN Degradation and Activating the PTEN/AKT/mTOR Pathway
   Xiaohong Li et al, 2023, Molecular Biotechnology CrossRef
3. Microglial activation in the motor cortex mediated NLRP3-related neuroinflammation and neuronal damage following spinal cord injury
   Xvlei Hu et al, 2022, Frontiers in Cellular Neuroscience CrossRef
4. Phosphorylated proteomics-based analysis of the effects of semaglutide on hippocampi of high-fat diet-induced-obese mice
   Xiaoyi Chen et al, 2023, Diabetology & Metabolic Syndrome CrossRef
5. Neuroprotective Effect of Morinda citrifolia on Behavioural and Biochemical Deficits in PTZ-induced Kindled Mice
   Moazzam Ali et al, 2023, Infectious Disorders - Drug Targets CrossRef
6. Mechanism of NLRP3 Inflammasome in Epilepsy and Related Therapeutic Agents
   Juan Chen et al, 2024, Neuroscience CrossRef
7. Muscone ameliorates myocardial ischemia‒reperfusion injury by promoting myocardial glycolysis
   Xin Gu et al, 2023, Heliyon CrossRef
8. Semaglutide, a novel glucagon-like peptide-1 agonist, amends experimental autoimmune encephalomyelitis-induced multiple sclerosis in mice: Involvement of the PI3K/Akt/GSK-3β pathway
   Mohamed A Sadek et al, 2023, International Immunopharmacology CrossRef
9. Decreased cognitive function of ALG13KO female mice may be related to the decreased plasticity of hippocampal neurons
   Baorui Guo et al, 2022, Neuropeptides CrossRef
10. The Neurovascular Unit Dysfunction in the Molecular Mechanisms of Epileptogenesis and Targeted Therapy
    Xiuxiu Liu et al, 2024, Neuroscience Bulletin CrossRef
11. Pyroptosis and gasdermins—Emerging insights and therapeutic opportunities in metabolic dysfunction-associated steatohepatitis
    Christian Stoess et al, 2023, Frontiers in Cell and Developmental Biology CrossRef
12. Glucagon-like peptide-1 receptor agonist, semaglutide attenuates chronic liver disease-induced skeletal muscle atrophy in diabetic mice
    Satoshi Iwai et al, 2023, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
13. Dulaglutide Ameliorates Intrauterine Adhesion by Suppressing Inflammation and Epithelial–Mesenchymal Transition via Inhibiting the TGF-β/Smad2 Signaling Pathway
    Yifan Wang et al, 2023, Pharmaceuticals CrossRef
14. Astragalus polysaccharides ameliorate epileptogenesis, cognitive impairment, and neuroinflammation in a pentylenetetrazole-induced kindling mouse model
    Yuling Lu et al, 2024, Frontiers in Pharmacology CrossRef
15. Gut microbiota modification by diosgenin mediates antiepileptic effects in a mouse model of epilepsy
    Xinyu Li et al, 2023, Journal of Neurochemistry CrossRef
16. Semaglutide ameliorates lipopolysaccharide-induced acute lung injury through inhibiting HDAC5-mediated activation of NF-κB signaling pathway
    Zeyu Jiang et al, 2022, Human & Experimental Toxicology CrossRef
17. Glabridin reduces neuroinflammation by modulating inflammatory signals in LPS-induced in vitro and in vivo models
    Jiyu Weng et al, 2024, Inflammopharmacology CrossRef
18. Anti-inflammatory benefits of semaglutide: State of the art
    Habib Yaribeygi et al, 2024, Journal of Clinical & Translational Endocrinology CrossRef
19. Reducing neuroinflammation via therapeutic compounds and lifestyle to prevent or delay progression of Parkinson’s disease
    Elodie Kip et al, 2022, Ageing Research Reviews CrossRef
20. A Combination of Curcuma longa and Diazepam Attenuates Seizures and Subsequent Hippocampal Neurodegeneration
    Chirlene Pinheiro Nascimento et al, 2022, Frontiers in Cellular Neuroscience CrossRef